What is she best known for?
The fields of study she is best known for:
- Gene
- Internal medicine
- Cancer
Her scientific interests lie mostly in Internal medicine, Cardiology, Cancer research, Cell biology and In vivo.
Her Internal medicine study frequently draws connections to adjacent fields such as Endocrinology.
Her work is connected to Coronary artery disease, Coronary arteries and Vasodilation, as a part of Cardiology.
Her Cancer research study integrates concerns from other disciplines, such as Cell growth, Progerin, LMNA, Anatomy and Progeria.
Her In vivo research includes elements of Gene transfer, Liposome, Recombinant DNA, DNA and Pharmacology.
The Recombinant DNA study combines topics in areas such as Molecular biology, Genetic transfer, Transfection and Pathology.
Her most cited work include:
- Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease. (1079 citations)
- Direct gene transfer with DNA-liposome complexes in melanoma: expression, biologic activity, and lack of toxicity in humans (843 citations)
- A Tale of Coronary Artery Disease and Myocardial Infarction (626 citations)
What are the main themes of her work throughout her whole career to date?
Her primary areas of investigation include Internal medicine, Cardiology, Cell biology, In vivo and Cancer research.
Her Internal medicine study frequently draws connections between related disciplines such as Endocrinology.
The various areas that Elizabeth G. Nabel examines in her Cardiology study include Impact factor and Asymptomatic, Surgery.
Her In vivo study incorporates themes from Gene transfer and Gene.
Her Cancer research research is multidisciplinary, relying on both Cancer, Cell growth, Restenosis, Cyclin-dependent kinase and Immunology.
Elizabeth G. Nabel has researched Vasodilation in several fields, including Vasoconstriction and Coronary arteries.
She most often published in these fields:
- Internal medicine (25.44%)
- Cardiology (17.07%)
- Cell biology (14.63%)
What were the highlights of her more recent work (between 2008-2018)?
- Internal medicine (25.44%)
- Pathology (9.76%)
- Vascular disease (4.53%)
In recent papers she was focusing on the following fields of study:
Elizabeth G. Nabel mainly focuses on Internal medicine, Pathology, Vascular disease, Lung and Gerontology.
Her study in Internal medicine is interdisciplinary in nature, drawing from both Endocrinology, Oncology and Cardiology.
The study incorporates disciplines such as Cancer research, Protein-Arginine N-Methyltransferases and Kinase in addition to Endocrinology.
Her studies in Pathology integrate themes in fields like Progerin, Umbilical vein, Progeria and Cellular senescence.
She works mostly in the field of Vascular disease, limiting it down to concerns involving Myocardial infarction and, occasionally, MEDLINE, Coronary artery disease, Improved survival, Arteriolosclerosis and Stroke.
Her Lung research incorporates themes from Progenitor cell, Progenitor, Reprogramming, Immunology and Intensive care medicine.
Between 2008 and 2018, her most popular works were:
- A Tale of Coronary Artery Disease and Myocardial Infarction (626 citations)
- Cardiovascular Pathology in Hutchinson-Gilford Progeria: Correlation With the Vascular Pathology of Aging (256 citations)
- Progerin and telomere dysfunction collaborate to trigger cellular senescence in normal human fibroblasts (213 citations)
In her most recent research, the most cited papers focused on:
- Gene
- Internal medicine
- Cancer
Her primary areas of study are Internal medicine, Myocardial infarction, Vascular disease, Cell aging and Pathology.
Elizabeth G. Nabel combines subjects such as Tyrosine phosphorylation, Methylation and Cardiology with her study of Internal medicine.
Her Cardiology study combines topics in areas such as Dementia, MEDLINE and Improved survival.
Her research in Vascular disease intersects with topics in Pulse wave velocity, Pulse pressure and Disease.
Her research investigates the connection between Pathology and topics such as Plaque instability that intersect with issues in Mesenchymal stem cell.
Her research integrates issues of Progerin, Progeria and Senescence in her study of Arteriolosclerosis.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
